Search results for "oral lichen planu certolizumab crohn"

showing 1 items of 1 documents

Oral lichen planus after certolizumab pegol treatment in a patient with Crohn's disease

2011

Dear Sir , Lichen planus (LP) is a relatively uncommon inflammatory dermatosis of the mucocutaneous surfaces that can present with a variety of clinical manifestations and, most commonly, affecting middle-aged adults. The disease course may be short or chronic, although most cases may resolve after 1 month to 7 years. The real prevalence of LP is unknown, but is estimated to be 1% in the USA.1 The pathogenesis of LP is not entirely understood. In general, activated T lymphocytes are recruited to the dermal–epidermal junction and induce apoptosis in basal keratinocytes. Both CD4+ and CD8+ T lymphocytes are found in the lichenoid infiltrate of LP, with a predominance of the latter cell type b…

education.field_of_studyCrohn's diseasemedicine.medical_specialtySettore MED/09 - Medicina Internaintegumentary systembusiness.industryPopulationMucocutaneous zoneoral lichen planu certolizumab crohnGastroenterologyGeneral Medicinemedicine.diseaseDermatologyPathogenesisstomatognathic diseasesBasal (phylogenetics)medicineOral lichen planusCertolizumab pegoleducationbusinessCD8medicine.drugJournal of Crohn's and Colitis
researchProduct